Curebase and Flow Neuroscience launch clinical trial to test at-home headset for depression
Device delivers currents to the brain to restore activity usually lowered in depression patients - News - PharmaTimes
Source: pharmatimes.com
Page 4 - Tom Lemberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tom Lemberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tom Lemberg Today - Breaking & Trending Today
Curebase, Flow Neuroscience Announce Joint Clinical Trial for the use of an at-home tDCS device for treating depression
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Flow Neuroscience, creator of Europe's only medically approved...
Source: prnewswire.com
Curebase Adds Pharma, Clinical Research Veteran to Advisory Board
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has named Lars-Olof "Lollo" Eriksson to its Advisory Board. Eriksson...
Source: prnewswire.com
Curebase - AlleyWatch
Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers. Founded by Tom Lemberg in 2017, Curebase is backed by investors that include GGV Capital, StartX (Stanford-StartX Fund), Y Combinator, Xfund, Bold Capital Partners and is headquartered in San Francisco.
Source: alleywatch.com
Curebase thinks the future of clinical testing is decentralized, and raises $40M to prove it – TechCrunch
The medical world has come a long way from the traditional, centralized way of conducting clinical trials, but there’s still a lot of modernization left to do. Curebase provides the infrastructure — physical and digital — for distributed clinical trials, and will be doubling down on its success with a new $40 million funding round. […]
Source: techcrunch.com